Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BVS | RLMD | ZVRA | ||
| Company | Bioventus Inc Cl A | Relmada Therapeutics Inc | Zevra Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.86 | 7.20 | 11.45 | ||
| High | 8.90 | 7.31 | 11.74 | ||
| Low | 8.51 | 7.09 | 11.36 | ||
| Latest | 8.51 | 7.21 | 11.59 | ||
| Change | -0.36 | -0.04 | +0.19 | ||
| % Change | -4.06% | -0.55% | +1.67% | ||
| Volume | 711,300 | 946,300 | 2,260,600 | ||
| 20-Day Average Volume | 627,795 | 936,175 | 1,968,035 | ||
| Previous Close | 8.87 | 7.25 | 11.40 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.06 | 7.27 | 10.77 | ||
| 20-Day Raw Stochastic | 4.20% | 56.83% | 77.07% | ||
| 20-Day Relative Strength | 36.92 | 52.65 | 60.23 | ||
| Weighted Alpha | +26.20 | +272.94 | +30.13 | ||
| Today's Opinion | 40% Buy | 72% Buy | 100% Buy | ||
| Previous Opinion | 40% Buy | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.37% since 05/21/26 | unch since 05/21/26 | +10.49% since 05/21/26 | ||
| Low | 8.39 on 05/27/26 | 6.88 on 05/26/26 | 10.01 on 05/22/26 | ||
| High | 9.76 on 05/22/26 | 7.50 on 05/22/26 | 11.74 on 05/29/26 | ||
| 1-Month | |||||
| %Chg | -12.00% since 04/29/26 | -2.17% since 04/29/26 | +19.86% since 04/29/26 | ||
| Low | 8.39 on 05/27/26 | 6.17 on 05/18/26 | 9.75 on 04/30/26 | ||
| High | 11.25 on 05/07/26 | 8.00 on 05/06/26 | 12.06 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | -3.08% since 02/27/26 | +58.11% since 02/27/26 | +29.79% since 02/27/26 | ||
| Low | 8.11 on 03/09/26 | 4.23 on 03/05/26 | 8.42 on 03/06/26 | ||
| High | 11.25 on 05/07/26 | 8.00 on 05/06/26 | 12.06 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | +12.12% since 11/28/25 | +59.87% since 11/28/25 | +37.49% since 11/28/25 | ||
| Low | 7.01 on 12/08/25 | 3.22 on 02/04/26 | 8.01 on 12/19/25 | ||
| High | 11.25 on 05/07/26 | 8.00 on 05/06/26 | 12.06 on 05/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 710,883 | 756,257 | 685,143 | ||
| Shares Outstanding, K | 83,535 | 104,890 | 59,115 | ||
| Annual Sales | 568,090,000 | 0 | 106,470,000 | ||
| Annual Net Income | 22,730,000 | -57,390,000 | 83,230,000 | ||
| Last Quarter Sales | 132,090,000 | 0 | 36,220,000 | ||
| Last Quarter Net Income | 3,110,000 | -19,050,000 | 37,890,000 | ||
| 60-Month Beta | 0.72 | 0.43 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 05/06/26 | -0.22 on 05/12/26 | 0.18 on 05/06/26 | ||
| Earnings Date | 08/05/26 | 08/06/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 11.83 | 0.00 | 8.98 | ||